— Know what they know.
Not Investment Advice

PODD

Insulet Corporation
1W: +3.3% 1M: -8.8% 3M: -21.6% YTD: -19.7% 1Y: -14.6% 3Y: -26.2% 5Y: -15.8%
$227.10
-1.53 (-0.67%)
After Hours: $229.75 (+2.65, +1.17%)
NASDAQ · Healthcare · Medical - Devices · $16.0B · Alpha Radar Strong Sell · Power 42
Smart Money Score
Bullish 75
Insider+$18.6M
Congress
ETF Holdings
Key Statistics
Market Cap$16.0B
52W Range216.49-354.88
Volume993,297
Avg Volume978,179
Beta1.44
Dividend
Analyst Ratings
36 Buy 10 Hold 3 Sell
Consensus Buy
Company Info
CEOAshley A. McEvoy
Employees5,400
SectorHealthcare
IndustryMedical - Devices
IPO Date2007-05-15
100 Nagog Park
Acton, MA 01720
US
978 600 7000
About Insulet Corporation

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Recent Insider Trades

NameTypeSharesPriceDate
Singh Prem F-InKind 207 $246.61 2026-02-27
Singh Prem F-InKind 62 $246.61 2026-02-27
Cousin Laetitia F-InKind 200 $246.61 2026-02-27
Cousin Laetitia F-InKind 53 $246.61 2026-02-27
Budden Lauren F-InKind 119 $246.61 2026-02-27

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms